Newsfeed
Every published oncology item from an approved source, most recent first. No account required — this is the unfiltered stream, not personalized to any follows.
Items are tagged with the biomarkers and tumour types they resolve to; each tag opens that record, and every record’s page carries the same items back.
This demo serves a captured snapshot of the feed, not a live connection to the sources.
PubMed Central · Sep 1, 2026
Associations of neighborhood deprivation with breast cancer tumor genomics, targeted treatment use, and survival.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Integrating Molecular Classification Based on FGFR3, KRAS, HRAS, and TP53 Mutation With TNM Staging Modestly Improves Prediction of Prognosis of Upper Tract Urothelial Carcinoma After Surgery.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Artificial Intelligence-Estimated Intrapancreatic Fat and Its Relationship to Familial and Germline Pancreatic Cancer Risk.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Preoperative RDW-Albumin Ratio as a Prognostic Biomarker in Gastric Cancer Surgery.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Plant-Based α-Linolenic Acid as a Superior Nutraceutical to Modulates Apoptosis, Hypoxic Signaling, and Lipid Metabolic Pathway in Breast Cancer: A Comparative Preclinical Study.
Read at PubMed CentralPubMed Central · Sep 1, 2026
High-definition spatial transcriptomics visualizes the cellular and molecular architecture underlying perineural invasion in localized prostate cancer.
Read at PubMed CentralPubMed Central · Sep 1, 2026
A Technique for the Generation of Mucosal and Acral Melanoma Cell Lines.
Read at PubMed CentralPubMed Central · Sep 1, 2026
CPT1A through succinylation regulates the CTCF/LINC01503‒91aa feedback loop to promote gemcitabine resistance in pancreatic ductal adenocarcinoma.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Regional Variation in Bladder Cancer Clinical Trial Availability in the US.
Read at PubMed CentralPubMed Central · Sep 1, 2026
4-2 VHL-Recruiting PROTAC Inhibits the Growth and Migration of Triple Negative Breast Cancer Cells by Triggering Pyroptosis Through Fas-Mediated IL-17 Signaling.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Small Extracellular Vesicle and Total Lipid Profiles Provide a Diagnostic Advantage Over CA-125 Across Ovarian Cancer Subtypes.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Eosinophil Proportion May Serve as a Candidate Biomarker for Adverse Events in Patients With Urothelial Carcinoma Treated With Enfortumab Vedotin.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Annona crassiflora seed extract modulates histological and molecular markers associated with prostate cancer progression in TRAMP mice.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Fatty Acid-Binding Protein 5 Potentially Regulates the Proliferation and Metastasis of Uveal Melanoma Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Addition of High-Dose Vitamin D3 to Standard Treatment in Patients With Metastatic Colorectal Cancer: The SOLARIS Randomized Clinical Trial (Alliance A021703).
Read at PubMed CentralPubMed Central · Sep 1, 2026
Integrative Multi-Omics Analysis Identifies Thrombosis-Associated Molecular Features Linked to Germline Susceptibility and Immune Cell Communication in Gastric Cancer.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Cathepsin V (CTSV) Shapes the Epigenetic-Immune Landscape of Bladder Cancer and Emerges as a Noninvasive Biomarker.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Real-World Outcomes of Olaparib in Japanese Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer: Exploratory Analysis of BRCA2 Loss and Microsatellite Instability Status.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Association of MDM2 rs2279744 and rs937282 polymorphisms with breast cancer susceptibility and circulating MDM2 and p53 levels in Bangladeshi women: A case-control study.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Dietary-Derived Corchorus olitorius L. Extract Suppresses KRAS-Mutant Pancreatic Cancer by Activating Ferritinophagy-Dependent Ferroptosis.
Read at PubMed Central